Gracell Biotechnologies Inc ADR (GRCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCL | CSTL | MNPR | ||
| Company | Gracell Biotechnologies Inc ADR | Castle Biosciences Inc | Monopar Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.26 | 25.56 | 105.47 | ||
| High | 10.28 | 25.63 | 110.23 | ||
| Low | 10.17 | 24.35 | 103.00 | ||
| Latest | 10.25 | 24.68 | 109.87 | ||
| Change | +0.01 | -0.80 | +4.17 | ||
| % Change | +0.05% | -3.12% | +3.95% | ||
| Volume | 6,417,100 | 408,900 | 229,800 | ||
| 20-Day Average Volume | 1,332,340 | 337,440 | 232,225 | ||
| Previous Close | 10.25 | 25.48 | 105.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.21 | 24.16 | 102.47 | ||
| 20-Day Raw Stochastic | 53.16% | 70.30% | 78.13% | ||
| 20-Day Relative Strength | 72.75 | 56.81 | 65.99 | ||
| Weighted Alpha | +228.20 | +13.04 | +102.83 | ||
| Today's Opinion | 100% Buy | 8% Sell | 88% Buy | ||
| Previous Opinion | 100% Buy | 8% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.87% since 02/13/24 | +2.17% since 07/17/26 | -1.12% since 07/17/26 | ||
| Low | 10.09 on 02/16/24 | 23.25 on 07/21/26 | 101.00 on 07/23/26 | ||
| High | 10.35 on 02/14/24 | 25.63 on 07/24/26 | 116.64 on 07/22/26 | ||
| 1-Month | |||||
| %Chg | +2.60% since 01/19/24 | +11.60% since 06/24/26 | +23.46% since 06/24/26 | ||
| Low | 9.97 on 01/22/24 | 22.24 on 06/25/26 | 85.70 on 06/26/26 | ||
| High | 10.44 on 02/09/24 | 25.63 on 07/24/26 | 116.64 on 07/22/26 | ||
| 3-Month | |||||
| %Chg | +109.61% since 11/21/23 | +0.92% since 04/24/26 | +106.52% since 04/24/26 | ||
| Low | 3.80 on 11/28/23 | 17.72 on 05/14/26 | 50.07 on 04/29/26 | ||
| High | 10.44 on 02/09/24 | 25.71 on 04/27/26 | 116.64 on 07/22/26 | ||
| 6-Month | |||||
| %Chg | +222.33% since 08/21/23 | -41.56% since 01/23/26 | +46.44% since 01/23/26 | ||
| Low | 2.10 on 10/04/23 | 17.72 on 05/14/26 | 50.07 on 04/29/26 | ||
| High | 10.44 on 02/09/24 | 44.28 on 01/26/26 | 116.64 on 07/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 744,950 | 748,696 | 736,030 | ||
| Shares Outstanding, K | 72,678 | 30,330 | 6,699 | ||
| Annual Sales | 0 | 344,230,000 | 0 | ||
| Annual Net Income | -88,080,000 | -24,160,000 | -13,720,000 | ||
| Last Quarter Sales | 0 | 83,680,000 | 0 | ||
| Last Quarter Net Income | -9,270,000 | -14,520,000 | -3,890,000 | ||
| 60-Month Beta | -0.33 | 1.00 | 1.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/23 | -0.49 on 05/06/26 | -0.46 on 05/14/26 | ||
| Earnings Date | 03/11/24 | 07/30/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||